AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nash, K. A.
Right arrow Articles by Wallace, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nash, K. A.
Right arrow Articles by Wallace, R. J., Jr.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2006, p. 3476-3478, Vol. 50, No. 10
0066-4804/06/$08.00+0     doi:10.1128/AAC.00402-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Intrinsic Macrolide Resistance in Rapidly Growing Mycobacteria{dagger}

Kevin A. Nash,1* Nadya Andini,1 Yansheng Zhang,2 Barbara A. Brown-Elliott,2 and Richard J. Wallace Jr.2

Department of Pathology, University of Southern California, and Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, California,1 Department of Microbiology, The University of Texas Health Center at Tyler, Tyler, Texas2

Received 31 March 2006/ Returned for modification 17 May 2006/ Accepted 14 July 2006


   ABSTRACT
Top
 Abstract
Text
 References
 
This study reports the discovery of erm genes in seven species of rapidly growing mycobacteria (RGM): Mycobacterium boenickei, M. goodii, M. houstonense, M. mageritense, M. neworleansense, M. porcinum, and M. wolinskyi. This study further substantiates the role of erm genes in intrinsic macrolide resistance in RGM.


   TEXT
Top
 Abstract
 Text
References
 
Several rapidly growing mycobacteria (RGM) are significant human pathogens, with approximately 90% of RGM infections being caused by Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum (3, 4). Other members of the M. fortuitum and Mycobacterium smegmatis groups cause most of the remaining RGM infections. Although the incidence of infections caused by some species of slowly growing nontuberculous mycobacteria appears to be declining, there is evidence that RGM infections may be increasing or increasingly recognized (5). Many pathogenic RGM species are considered susceptible to the newer macrolides (e.g., clarithromycin), and these agents are important components in the treatment of RGM infections (13). However, several RGM species express intrinsic macrolide resistance, including Mycobacterium goodii, Mycobacterium houstonense, Mycobacterium mageritense, and Mycobacterium wolinskyi (2). Previous studies have shown that the novel rRNA methylase genes erm(38) and erm(39) confer inducible macrolide resistance on M. fortuitum and M. smegmatis, respectively (8, 9). Thus, the objective of this study was to determine if other clinically important RGM have similar erm genes.

Southern blot analysis with an erm(38)-derived probe (8, 9) indicated that M. mageritense strain 961635 had DNA similar to that of erm(38) of M. smegmatis. Genetic complementation of the erm(38) knockout variant M. smegmatis ermKO4, using methods described elsewhere (9), isolated a 2.8-kbp M. mageritense DNA fragment that conferred resistance (MIC ≥ 128 µg/ml) to clarithromycin, clindamycin, erythromycin, spiramycin, and the ketolide HMR3004, but not to quinupristin (streptogramin B). Sequencing of the M. mageritense DNA fragment identified a gene encoding a 251-amino-acid polypeptide that was 77% identical to Erm(39) of M. fortuitum (GenBank accession no. AAR92235) and 71% identical to the first 264 amino acids of Erm(38) of M. smegmatis (GenBank accession no. AAN86837). The M. mageritense erm gene sequence was submitted to the Nomenclature Center for MLS Genes maintained by Marilyn C. Roberts (11, 12) and was designated erm(40). Using erm(40)-specific primers (MM1 and MM2) (Table 1) and methods described elsewhere (9), this gene was detected by PCR in 11/11 clinical isolates of M. mageritense.


View this table:
[in this window]
[in a new window]
  		TABLE 1. PCR primers used in this studya

 
The sequences of the erm(38), erm(39), and erm(40) regions (GenBank accession no. AY154657, AY487229, and AY570506) provided the basis for designing consensus primers (Table 1) targeting the RGM erm genes and flanking DNA. Using these primers, erm genes were detected by PCR in Mycobacterium boenickei (10 strains or isolates tested), M. goodii (1 strain or isolate tested), M. houstonense (3 strains or isolates tested), Mycobacterium neworleansense (1 strain or isolate tested), Mycobacterium porcinum (2 strains or isolates tested), and M. wolinskyi (4 strains or isolates tested). No evidence of a related erm gene was found for M. abscessus (7 strains or isolates tested), M. chelonae (2 strains or isolates tested), Mycobacterium flavescens (1 strain or isolate tested), Mycobacterium immunogenum (1 strain or isolate tested), Mycobacterium peregrinum (5 strains or isolates tested), Mycobacterium senegalense (4 strains or isolates tested), and Mycobacterium thermoresistibile (1 strain or isolate tested).

Sequencing of the erm genes and surrounding DNA of the erm-positive species was enabled by using different combinations of the consensus primers (Table 1). The encoded amino acid sequences of the erm genes of M. boenickei, M. goodii, M. houstonense, M. neworleansense, M. porcinum, and M. wolinskyi, along with the previously described erm genes of M. fortuitum (9) and M. smegmatis (8), were found to be highly conserved, with a mean identity of 77% (range, 68 to 99%) (see Table S1 in the supplemental material). Following the guidelines of Roberts (11), the erm alleles in different RGM fall into three existing Erm classes: Erm(38) for M. goodii and M. smegmatis; Erm(39) for M. boenickei, M. fortuitum, M. houstonense, M. neworleansense, and M. porcinum; and Erm(40) for M. mageritense and M. wolinskyi. Furthermore, the predicted phylogenic relationship between the amino acid sequences of the RGM erm alleles and other closely related Erm classes (Fig. 1A) showed that the RGM erm genes formed a distinct clade of the erm phylogenic tree. This clade was consistent with the phylogeny of RGM predicted by molecular analysis of other genes (6). Furthermore, the RGM Erm node appears to have "emerged" more recently than the other Erm classes, which are largely derived from antibiotic-producing Actinomycetales (e.g., Streptomyces). This suggests that the RGM erm genes were acquired after the divergence of the RGM from other members of this order.


Figure 1
View larger version (12K):
[in this window]
[in a new window]
  		FIG. 1. (A) Phylogram showing the predicted relationships of the RGM Erm proteins, with the representative alleles of the eight most closely related Erm classes, and rooted on Erm(C) of Staphylococcus aureus (GenBank accession no. AAA20192). The Erm class representatives (with GenBank accession numbers) are Erm(30) of Streptomyces venezuelae (AAC69328), Erm(31) of S. venezuelae (AAC69327), Erm(36) of Micrococcus luteus (AAL68827), Erm(I) of Streptomyces mycarofaciens (A60725), Erm(N) of Streptomyces fradiae (CAA66307), Erm(U) of Streptomyces lincolnensis (CAA55770), Erm(W) of Micromonospora griseorubida (P43433), and Erm(X) of Corynebacterium jeikeium (AAK28910). For the RGM Erm proteins, Erm(38), Erm(39), and Erm(40), the allele (or RGM species) is indicated by the letters after the right parenthesis: bo, M. boenickei; fo, M. fortuitum; go, M. goodii; ho, M. houstonense; ma, M. mageritense; ne, M. neworleansense; po, M. porcinum; sm, M. smegmatis; and wo, M. wolinskyi. The scale bar shows the evolutionary distance (i.e., the amount of divergence, or time since splitting, from a theoretical common ancestor). (B and C) The genetic organization of the folD regions of erm gene-positive and erm gene-negative RGM, respectively. The shaded genes are similar (>64% amino acid identity) to M. tuberculosis strain H37Rv genes Rv3342 (GenBank accession no. CAA17114), Rv3355c (GenBank accession no. NP_217872), and folD (GenBank accession no. NP_217873). Other genes are those encoding TR, a putative tetR family transcriptional regulator, and pgaE, a putative polyketide synthase, and zeta toxin-like, containing a zeta toxin conserved domain (Pfam06414) and ~50% amino acid identity to conserved hypothetical genes of Polaromonas spp. (GenBank accession no. EAM36411) and Xanthomonas oryzae (GenBank accession no. AAW75612). ORF, open reading frame with a likely ribosome binding site (AAGGGA).

 
Conservation of the RGM erm genes was not only reflected in the coding regions, but also in the flanking genes (Fig. 1B), i.e., the erm gene regions of the RGM show synteny. Specifically, the erm genes were bound by the 3355 and folD genes downstream and the TR (putative transcriptional regulator) and pgaE genes upstream. Furthermore, PCR mapping indicated that the 3342 gene was upstream of the pgaE gene in all erm-positive RGM species. Using the consensus primers to amplify and sequence the 3342-folD regions of the erm-negative RGM species M. peregrinum (GenBank accession no. DQ435604) and M. senegalense (GenBank accession no. DQ435605), a gene organization similar to that of erm-positive RGM species, minus the erm gene, was revealed (Fig. 1C). Intriguingly, M. peregrinum, like M. fortuitum, has a zeta toxin-like gene absent in other RGM. Zeta toxin/antitoxin genes provide a mechanism for plasmid maintenance (7). Thus, the zeta toxin-like gene may be the "smoking gun" for the acquisition event of the erm gene (and possibly the pgaE and TR genes) from a plasmid.

Sequencing of the folD regions of M. abscessus (isolates MAB30 and MC719) and M. chelonae (strain ATCC 35752T) revealed that the 3342 and folD genes were separated by 0.8 kbp of DNA (GenBank accession no. DQ144643 and DQ144644) (Fig. 1C). Although a possible open reading frame was identified in this region, BLAST analysis (1) revealed no convincing alignments with other sequences (all had <30% identity). In fact, BLAST searching of the current completely sequenced mycobacteria (through the NCBI website [http://www.ncbi.nlm.nih.gov/]) suggested that the pgaE and TR genes were found only in erm-positive RGM species and M. peregrinum and M. senegalense. This in turn suggested that M. peregrinum and M. senegalense originally had erm genes that were subsequently deleted.

As previously found for M. fortuitum and M. smegmatis (8, 9), M. boenickei, M. houstonense isolate 14133, M. neworleansense, and M. porcinum appeared susceptible to clarithromycin (MIC < 4 µg/ml) on standard susceptibility testing (10). However, as demonstrated with M. houstonense isolate 14133, overnight incubation in clarithromycin (0.1 µg/ml) increased the clarithromycin MIC to > 128 µg/ml. The clarithromycin MIC remained at ≤2 µg/ml for organisms incubated in the absence of macrolide. Thus, these results provide further evidence that macrolide resistance in RGM species can be inducible. Intriguingly, M. houstonense isolate 2014 and M. mageritense isolate 961635 were constitutively resistant to macrolide-lincosamide-ketolide agents (MIC > 128 µg/ml), yet reverse transcription-PCR analysis (using methods described elsewhere [8, 9]) indicated that the erm mRNA levels were ~10-fold higher in organisms preincubated for 2 h in 0.1 µg/ml clarithromycin or HMR3004 (data not shown). Thus, the results were consistent with RGM erm genes being inducible at the molecular level, even in organisms deemed constitutively resistant by standard susceptibility testing.

In conclusion, erm genes are present in a range of pathogenic RGM species, including species that are considered macrolide susceptible as currently defined by the Clinical and Laboratory Standards Institute (formerly NCCLS) (10). This, with the finding that all RGM erm genes are inducible at the molecular level, suggests that the results of routine susceptibility testing with macrolides should be interpreted with caution, especially for species of the M. fortuitum and M. smegmatis groups. Furthermore, induction of macrolide-lincosamide-ketolide resistance needs to be considered when assessing new macrolide-ketolide agents for potential antimycobacterial activity.

Nucleotide sequence accession numbers. The RGM erm regions and the erm gene-encoded polypeptides have been submitted to GenBank under the following accession numbers: M. boenickei, DQ144638 and AAZ76615; M. goodii, DQ144639 and AAZ76618; M. houstonense, DQ144640 and AAZ76622; M. mageritense, AY570506 and AAS76623; M. neworleansense, DQ144641 and AAZ76625; M. porcinum, DQ447745 and ABE01848; and M. wolinskyi, DQ144642 and AAZ76628. The folD regions of M. abscessus, M. peregrinum, and M. senegalense have been submitted to GenBank under accession numbers DQ144643, DQ435604, and DQ435605, respectively.


   ACKNOWLEDGMENTS
 
Funding for this study was provided by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) grant RO1-AI052291; the Department of Pathology and Laboratory Medicine, Childrens Hospital Los Angeles; and the Department of Microbiology, The University of Texas Health Center, Tyler, TX.


   FOOTNOTES
 
* Corresponding author. Mailing address: Department of Pathology and Laboratory Medicine, Saban Research Institute of Childrens Hospital Los Angeles, 4650 Sunset Blvd., Mailstop 103, Los Angeles, CA 90027. Phone: (323) 669-5670. Fax: (323) 666-7681. E-mail: kanash{at}usc.edu. Back

{dagger} Supplemental material for this article may be found at http://aac.asm.org/. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.[CrossRef][Medline]
  2. Brown, B. A., B. Springer, V. A. Steingrube, R. W. Wilson, G. E. Pfyffer, M. J. Garcia, M. C. Menendez, B. Rodriguez-Salgado, K. C. Jost, Jr., S. H. Chiu, G. O. Onyi, E. C. Bottger, and R. J. Wallace, Jr. 1999. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int. J. Syst. Bacteriol. 49:1493-1511.[Abstract/Free Full Text]
  3. Brown-Elliott, B. A., D. E. Griffith, and R. J. Wallace, Jr. 2002. Newly described or emerging human species of nontuberculous mycobacteria. Infect. Dis. Clin. N. Am. 16:187-220.[CrossRef][Medline]
  4. Brown-Elliott, B. A., and R. J. Wallace, Jr. 2002. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin. Microbiol. Rev. 15:716-746.[Abstract/Free Full Text]
  5. CDC. 1999. Nontuberculous mycobacteria reported to the public health laboratory information system by state public health laboratories United States, 1993-1996. Centers for Disease Control and Prevention, Atlanta, Ga.
  6. Devulder, G., M. Perouse de Montclosand, and J. P. Flandrois. 2005. A multigene approach to phylogenetic analysis using the genus Mycobacterium as a model. Int. J. Syst. Evol. Microbiol. 55:293-302.[Abstract/Free Full Text]
  7. Meinhart, A., J. C. Alonso, N. Strater, and W. Saenger. 2003. Crystal structure of the plasmid maintenance system epsilon/zeta: functional mechanism of toxin zeta and inactivation by epsilon 2 zeta 2 complex formation. Proc. Natl. Acad. Sci. USA 100:1661-1666.[Abstract/Free Full Text]
  8. Nash, K. A. 2003. Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). Antimicrob. Agents Chemother. 47:3053-3060.[Abstract/Free Full Text]
  9. Nash, K. A., Y. Zhang, B. A. Brown-Elliott, and R. J. Wallace, Jr. 2005. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J. Antimicrob. Chemother. 55:170-177.[Abstract/Free Full Text]
  10. NCCLS. 2003. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes, 1st ed. Approved standard M24-A, vol. 23. NCCLS, Villanova, Pa.
  11. Roberts, M. C. 21 February 2005, accession date. Nomenclature Center for MLS Genes. [Online.] http://faculty.washington.edu/marilynr/.
  12. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.[Free Full Text]
  13. Wallace, R. J., Jr. 1997. J. Glassroth, D. E. Griffith, K. N. Olivier, J. L. Cook, and F. Gordin. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156:1S-25S.

Antimicrobial Agents and Chemotherapy, October 2006, p. 3476-3478, Vol. 50, No. 10
0066-4804/06/$08.00+0     doi:10.1128/AAC.00402-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nash, K. A.
Right arrow Articles by Wallace, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nash, K. A.
Right arrow Articles by Wallace, R. J., Jr.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS